NANOSCALE BIOMAGNETICS SOCIEDAD LIMITADA

Their core work

Nanoscale Biomagnetics is a Spanish SME specializing in magnetic nanoparticle technologies and their applications in both biomedical and industrial settings. They develop equipment and techniques for controlled magnetic heating (hyperthermia), enabling applications ranging from triggered drug delivery to thermally-activated biocatalytic processes. Their core competence lies at the intersection of nanotechnology hardware and biological applications — they provide the instruments and know-how that allow researchers and manufacturers to use alternating magnetic fields to precisely control nanoscale heating events.

What they specialise in

How they've shifted over time

Nanoscale Biomagnetics entered H2020 through medical device testing infrastructure (TBMED, 2019), then rapidly shifted toward fundamental nanoparticle science applied to industrial and pharmaceutical problems. Their more recent projects (HOTZYMES, HeatNMof) reveal a clear deepening into magnetic nanoparticle heating as a versatile enabling technology — applied both to industrial biocatalysis and targeted drug delivery. The trajectory suggests a company moving from broad medtech participation toward becoming a focused specialist in magnetically-controlled nanoscale processes.

Moving toward dual-use magnetic nanoactuation — expect future work combining industrial biomanufacturing with biomedical drug delivery platforms.

How they like to work

Nanoscale Biomagnetics operates exclusively as a consortium participant, never as coordinator, which is typical for a technology SME contributing specialized equipment or expertise to larger research efforts. Across 3 projects they have worked with 35 unique partners in 9 countries, indicating they are well-networked and sought after as a niche specialist. Their role pattern suggests they are brought in for their specific magnetic nanoparticle instrumentation capabilities rather than driving project direction.

Despite only 3 projects, they have built a broad network of 35 partners across 9 countries, reflecting participation in medium-to-large consortia. Their base in Zaragoza, Spain, connects them to research groups across Western and Southern Europe.

What sets them apart

Nanoscale Biomagnetics occupies a rare niche: they are a commercial provider of magnetic nanoparticle actuation technology that bridges the gap between nanomaterial science and real-world applications. While many academic groups study magnetic nanoparticles, few SMEs offer the instrumentation and applied expertise to deploy these technologies in both industrial biocatalysis and drug delivery. For consortium builders, they bring a ready-made hardware and methods package for any project requiring precise, remotely-controlled nanoscale heating.

Highlights from their portfolio

• HOTZYMES
  Largest funding (EUR 497K) and most innovative concept — using magnetic nanoparticle heating to thermally control multi-enzyme cascades for industrial biomanufacturing.
• HeatNMof
  An MSCA training network combining three frontier materials (plasmonic nanoparticles, magnetic nanoparticles, metal-organic frameworks) for targeted drug delivery — signals deep research credibility.